Wellington Management Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255M | Sell |
|
|||||
|
2025
Q1 | $232M | Buy |
|
|||||
|
2024
Q4 | $199M | Buy |
|
|||||
|
2024
Q3 | $82.8M | Sell |
|
|||||
|
2024
Q2 | $124M | Sell |
|
|||||
|
2024
Q1 | $138M | Sell |
|
|||||
|
2023
Q4 | $158M | Sell |
|
|||||
|
2023
Q3 | $149M | Sell |
|
|||||
|
2023
Q2 | $132M | Buy |
|
|||||
|
2023
Q1 | $119M | Sell |
|
|||||
|
2022
Q4 | $144M | Buy |
|
|||||
|
2022
Q3 | $81.7M | Buy |
|
|||||
|
2022
Q2 | $43.3M | Buy |
|
|||||
|
2022
Q1 | $36.5M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.5M | Sell |
|
|||||
|
2021
Q2 | $3.68M | Sell |
|
|||||
|
2021
Q1 | $3.71M | Sell |
|
|||||
|
2020
Q4 | $3.82M | Buy |
|
|||||
|
2020
Q3 | $2.33M | Sell |
|
|||||
|
2020
Q2 | $3.64M | Sell |
|
|||||
|
2020
Q1 | $3.67M | Sell |
|
|||||
|
2019
Q4 | $6.34M | Sell |
|
|||||
|
2019
Q3 | $64.4M | Buy |
|
|||||
|
2019
Q2 | $59.1M | Buy |
|
|||||
|
2019
Q1 | $5.96M | Buy |
|
|||||
|
2018
Q4 | $1.92M | Sell |
|
|||||
|
2018
Q3 | $136M | Sell |
|
|||||
|
2018
Q2 | $236M | Buy |
|
|||||
|
2018
Q1 | $197M | Sell |
|
|||||
|
2017
Q4 | $244M | Sell |
|
|||||
|
2017
Q3 | $226M | Buy |
|
|||||
|
2017
Q2 | $139M | Buy |
|
|||||
|
2017
Q1 | $104M | Buy |
|
|||||
|
2016
Q4 | $14.2M | Buy |
|
|||||
|
2016
Q3 | $17.5M | Sell |
|
|||||
|
2016
Q2 | $20.9M | Buy |
|
|||||
|
2016
Q1 | $16.6M | Sell |
|
|||||
|
2015
Q4 | $23.9M | Buy |
|
|||||
|
2015
Q3 | $15.4M | Sell |
|
|||||
|
2015
Q2 | $27.3M | Sell |
|
|||||
|
2015
Q1 | $23.3M | Sell |
|
|||||
|
2014
Q4 | $18.3M | Sell |
|
|||||
|
2014
Q3 | $13.6M | Buy |
|
|||||
|
2014
Q2 | $12.6M | Buy |
|
|||||
|
2014
Q1 | $9.12M | Sell |
|
|||||
|
2013
Q4 | $6.39M | Buy |
|
|||||
|
2013
Q3 | $3.79M | Sell |
|
|||||
|
2013
Q2 | $5.76M | Buy |
|